Titus B. Ball Sells $47K of BeOne Medicines Ltd (ONC) — SEC Form 4, Sep 03, 2026
Open-Market Net Sale · SEC Form 4
−$46,974
Equity position changed by -0.1%
Equity Position
97.9K sh
98,061 → 97,929
Equity Change
-0.1%
shares held after vs before
Filing Lag
2 business days
within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Reporting Owner
| Name | Relationship |
|---|---|
| Titus B. Ball CIK 0001675628 |
CAO
|
Titus B. Ball at BeOne Medicines Ltd
Full insider history
Bought (12 mo)
—
Sold (12 mo)
$759,619
More from this insider at BeOne Medicines Ltd
| 2026-11-10 | Sell | -$632,277 | View |
| 2026-06-15 | Sell | -$43,467 | View |
| 2026-06-10 | Sell | -$36,901 | View |
| 2025-09-04 | Sell | -$39,864 | View |
| 2025-06-12 | Sell | -$34,620 | View |
Non-Derivative Securities Transactions
Non-Derivative Holdings
| Title | Shares Held | Ownership |
|---|---|---|
| Ordinary Shares | 97,929 | Direct |
Footnotes (2)
- F1
- Each American Depositary Share represents 13 Ordinary Shares. Show more
- F2
- The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of August 31, 2023, subject to continued service. Show more
Related filings at BeOne Medicines Ltd
Institutional Holders
13F holders · Jun 30, 2026
284
institutional managers reporting a position
Largest by reported value
- Baker Bros. Advisors Lp $2.51B
- Primecap Management Co/Ca/ $1.43B
- Capital International Investors $1.2B
5%+ Holders · 13D/G
2 filers
-
Hhlr Advisors, Ltd. 4.9%
Other insiders at BeOne Medicines Ltd
-
Chan Henry Lee -$447K
-
Xiaodong Wang -$11.3M
-
Xiaodong Wang -$10.9M
-
Chan Henry Lee -$418K
-
Xiaodong Wang -$11.3M
GET /v1/forms/4/0001675628-26-000003
API docs
View Original SEC Filing